Vicki Poole Hoffmann

1.8k total citations
28 papers, 547 citations indexed

About

Vicki Poole Hoffmann is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Vicki Poole Hoffmann has authored 28 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 11 papers in Physiology and 7 papers in Neurology. Recurrent topics in Vicki Poole Hoffmann's work include Schizophrenia research and treatment (22 papers), Diet and metabolism studies (11 papers) and Bipolar Disorder and Treatment (11 papers). Vicki Poole Hoffmann is often cited by papers focused on Schizophrenia research and treatment (22 papers), Diet and metabolism studies (11 papers) and Bipolar Disorder and Treatment (11 papers). Vicki Poole Hoffmann collaborates with scholars based in United States, Canada and United Kingdom. Vicki Poole Hoffmann's co-authors include Leslie Citrome, Richard I. G. Holt, Daniel Walker, Jennie G. Jacobson, Michael Case, Jamie Karagianis, Tamás Treuer, Thomas A. Hardy, Ilya Lipkovich and Virginia L. Stauffer and has published in prestigious journals such as Psychiatry Research, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

Vicki Poole Hoffmann

26 papers receiving 521 citations

Peers

Vicki Poole Hoffmann

PMH

PHYSI

EDM

PHARM

Chathurie Suraweera Sri Lanka

Nicolás David Ramírez Spain

Luke Vano United Kingdom

Matthew A. Fuller United States

Robert L. Dufresne United States

Madhubhashinee Dayabandara Sri Lanka

Ikuko Kishida Japan

Enma Araujo de Baptista Venezuela

S. S. Ratnatunga Sri Lanka

Maria Teresa Cruz Lourenço Canada

Chathurie Suraweera Sri Lanka

Vicki Poole Hoffmann

308 ×0.8

PMH

147 ×0.8

PHYSI

116 ×1.0

EDM

76 ×1.0

83 ×1.3

PHARM

Citations per year, relative to Vicki Poole Hoffmann Vicki Poole Hoffmann (= 1×) peers Chathurie Suraweera

Countries citing papers authored by Vicki Poole Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Vicki Poole Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Poole Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Poole Hoffmann more than expected).

Fields of papers citing papers by Vicki Poole Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Poole Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Poole Hoffmann. The network helps show where Vicki Poole Hoffmann may publish in the future.

Co-authorship network of co-authors of Vicki Poole Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Poole Hoffmann. A scholar is included among the top collaborators of Vicki Poole Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Poole Hoffmann. Vicki Poole Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Detke, Holland C., Melissa P. DelBello, John Landry, et al.. (2016). A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder. Journal of Child and Adolescent Psychopharmacology. 26(10). 922–934. 11 indexed citations

Case, Michael, Jamie Karagianis, Kory Schuh, & Vicki Poole Hoffmann. (2013). Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy. Current Medical Research and Opinion. 29(11). 1533–1537. 2 indexed citations

Houston, John P., Jeffrey R. Bishop, Vicki L. Ellingrod, et al.. (2012). Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia. The Journal of Clinical Psychiatry. 73(8). 1077–1086. 21 indexed citations

Hoffmann, Vicki Poole, Michael Case, & Jennie G. Jacobson. (2011). Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine. The Journal of Clinical Psychiatry. 73(2). 216–223. 19 indexed citations

Fijal, Bonnie A., Virginia L. Stauffer, Bruce J. Kinon, et al.. (2011). Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone. The Journal of Clinical Psychiatry. 73(3). 367–371. 23 indexed citations

Citrome, Leslie, Richard I. G. Holt, Daniel Walker, & Vicki Poole Hoffmann. (2011). Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder. Clinical Drug Investigation. 31(7). 455–482. 89 indexed citations

Stauffer, Virginia L., Jennifer Gatz, Sara Kollack‐Walker, et al.. (2010). Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. BMC Psychiatry. 10(1). 89–89. 20 indexed citations

Hoffmann, Vicki Poole, Michael Case, Virginia L. Stauffer, Jennie G. Jacobson, & Robert R. Conley. (2010). Predictive Value of Early Changes in Triglycerides and Weight for Longer-Term Changes in Metabolic Measures During Olanzapine, Ziprasidone or Aripiprazole Treatment for Schizophrenia and Schizoaffective Disorder. Journal of Clinical Psychopharmacology. 30(6). 656–660. 16 indexed citations

Case, Michael, Tamás Treuer, Jamie Karagianis, & Vicki Poole Hoffmann. (2010). The potential role of appetite in predicting weight changes during treatment with olanzapine. BMC Psychiatry. 10(1). 72–72. 24 indexed citations

10.

Houston, John P., Jeffrey R. Bishop, Vicki L. Ellingrod, et al.. (2010). Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women. Psychiatry Research. 187(1-2). 74–79. 20 indexed citations

11.

Stauffer, Virginia L., et al.. (2009). Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis. BMC Psychiatry. 9(1). 12–12. 19 indexed citations

12.

Treuer, Tamás, et al.. (2009). Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study. The World Journal of Biological Psychiatry. 10(4-3). 729–740. 47 indexed citations

13.

Bushe, Chris, et al.. (2009). Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia. Journal of Psychopharmacology. 24(7). 1001–1009. 25 indexed citations

14.

Karagianis, J., Loren D. Grossman, John Landry, et al.. (2009). A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study. Schizophrenia Research. 113(1). 41–48. 26 indexed citations

15.

Karagianis, Jamie, Vicki Poole Hoffmann, Belén Arranz, et al.. (2008). Orally disintegrating olanzapine and potential differences in treatment‐emergent weight gain. Human Psychopharmacology Clinical and Experimental. 23(4). 275–281. 11 indexed citations

16.

Lipkovich, Ilya, Jennie G. Jacobson, Thomas A. Hardy, & Vicki Poole Hoffmann. (2008). Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder. BMC Psychiatry. 8(1). 78–78. 21 indexed citations

17.

Citrome, Leslie, et al.. (2007). Risk of Treatment-Emergent Diabetes Mellitus in Patients Receiving Antipsychotics. Annals of Pharmacotherapy. 41(10). 1593–1603. 41 indexed citations

18.

Lipkovich, Ilya, Jonna Ahl, Russell Nichols, Thomas A. Hardy, & Vicki Poole Hoffmann. (2007). Weight Changes During Treatment With Olanzapine in Older Adult Patients With Dementia and Behavioral Disturbances. Journal of Geriatric Psychiatry and Neurology. 20(2). 107–114. 8 indexed citations

19.

Hoffmann, Vicki Poole, et al.. (2005). Wellness Intervention for Patients With Serious and Persistent Mental Illness. The Journal of Clinical Psychiatry. 66(12). 1576–1579. 35 indexed citations

20.

Tschentscher, Frank, et al.. (2000). Identification and efficient genotyping of an (A)_n/(T)_m polymorphism within the 5′ untranslated region of the human IL6 gene. European Journal of Immunogenetics. 27(1). 1–3. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact